Header Logo

Connection

Ian Sanne to Pharmacogenetics

Back to Details
This is a "connection" page, showing publications Ian Sanne has written about Pharmacogenetics.
Ian Sanne
Connection Strength
0,030
Pharmacogenetics
  1. Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. Clin Infect Dis. 2015 Jun 15; 60(12):1860-3.
    View in: PubMed
    Score: 0,030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.